2 results
Approved WMOCompleted
Primary Safety Objective * Proportion of patients who complete 24 weeks of combination treatment on pirfenidone at a dose of 1602*2403 mg/d and nintedanib at a dose of 200*300 mg/d Secondary Safety Objective * Proportion of patients who discontinue…
Approved WMOCompleted
We aim to evaluate the effectiveness of 1) home-based exercise training program supported by tablet computer and coaching on physical function and 2) increased dietary protein intake during home-based exercise training program supported by tablet…